Successful pregnancy and delivery on prasugrel treatment: Considerations for the use of dual antiplatelet therapy during pregnancy in clinical practice

Journal of Thrombosis and Thrombolysis

Volumn 36, Issue 3, 2013, Pages 348-351

  Tello Montoliu, Antonio ^a   Seecheran, Naveen A ^a   Angiolillo, Dominick J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antiplatelet therapy; Prasugrel; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; ENOXAPARIN; GLYCERYL TRINITRATE; LISINOPRIL; METOPROLOL; MORPHINE; OXYTOCIN; PRASUGREL; TIROFIBAN;

ACUTE CORONARY SYNDROME; ADULT; AFRICAN AMERICAN; ARTICLE; CASE REPORT; CESAREAN SECTION; CHILDBIRTH; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LENGTH OF STAY; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREGNANCY; PREGNANCY TEST; PREGNANT WOMAN; PRIORITY JOURNAL; SECONDARY PREVENTION; ST SEGMENT ELEVATION; T WAVE; THORAX PAIN; THROMBOSIS;

ADULT; FEMALE; HUMANS; LIVE BIRTH; MYOCARDIAL ISCHEMIA; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES;

EID: 84884821709     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0830-7     Document Type: Article

References (17)

1. Wilson AM, Boyle AJ, Fox P (2004) Management of ischaemic heart disease in women of child-bearing age. Intern Med J 34:694-697
2. Kealey A (2010) Coronary artery disease and myocardial infarction in pregnancy: A review of epidemiology, diagnosis, and medical and surgical management. Can J Cardiol 26:185-189
3. James AH, Abel DE, Brancazio LR (2006) Anticoagulants in pregnancy. Obstet Gynecol Surv 61:59-69
4. Duley L, Henderson-Smart D, Knight M, King J (2001) Antiplatelet drugs for prevention of pre-eclampsia and its consequences: Systematic review. BMJ 322:329-333
5. Tello-Montoliu A, Tomasello SD, Ferreiro JL, Ueno M, Seecheran N, Desai B, Kodali M, Box L, Zenni M, Guzman L, Bass TA, Angiolillo DJ (2012) Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: Results of a prospective randomized study. J Am Coll Cardiol 59:1681-1687
6. Sharland G (2012) Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all? Future Cardiol 8:189-202
7. Rutherford JD (1998) Coronary artery disease in the childbearing age. In: Elkayam U, Gleicher N (eds) Cardiac problems in pregnancy. Diagnosis and management of maternal and fetal heart disease, 3rd edn. Wiley-Liss Inc, New York, pp 121-30
8. Klinzing P, Markert UR, Liesaus K, Peiker G (2001) Case report: Successful pregnancy and delivery after myocardial infarction and essential thrombocythemia treated with clopidogrel. Clin Exp Obstet Gynecol 28:215-216
9. De Santis M, De Luca C, Mappa I, Cesari E, Mazza A, Quattrocchi T, Caruso A (2011) Clopidogrel treatment during pregnancy: A case report and a review of literature. Intern Med 50:1769-1773
10. Arimura T, Mitsutake R, Miura S, Nishikawa H, Kawamura A, Saku K (2009) Acute myocardial infarction associated with pregnancy successfully treated with percutaneous coronary intervention. Intern Med 200948:1383-1386
11. Myers GR, Hoffman MK, Marshall ES (2011) Clopidogrel use throughout pregnancy in a patient with a drug-eluting coronary stent. Obstet Gynecol 118:432-433
12. Santiago-Díaz P, Arrebola-Moreno AL, Ramírez- Hernández JA, Melgares-Moreno R (2009) Platelet antiaggregants in pregnancy. Rev Esp Cardiol 62:1197-1198
13. Tomasello SD, Tello-Montoliu A, Angiolillo DJ (2011) Prasugrel for the treatment of coronary thrombosis: A review of pharmacological properties, indications for use and future development. Expert Opin Investig Drugs 20:119-133
14. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, Brown DL, Heit JA, Mulroy MF, Rosenquist RW, Tryba M, Yuan CS (2010) Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (third edition). Reg Anesth Pain Med 35:64-101
15. Abualsaud AO, Eisenberg MJ (2010) Perioperative management of patients with drug-eluting stents. JACC Cardiovasc Interv 3:131-142
16. Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, Voeltz MD, Chandna H, Ramaiah C, Brtko M, Cannon L, Dyke C, Liu T, Montalescot G, Manoukian SV, Prats J, Topol EJ, BRIDGE Investigators (2012) Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial. JAMA 307:265-274
17. Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD (2011) Impact of the everolimus-eluting stent on stent thrombosis a meta-analysis of 13 randomized trials. J Am Coll Cardiol 58:1569-1577